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Fetal life is a critical step in the development 
of male reproductive functions. Indeed, the 
two major functions of the testis, gameto-
genesis and steroidogenesis, take place dur-
ing this period. In humans, testis formation 
begins by the migration of primordial germ 
cells (PGCs) from extraembryonic areas to 
the genital ridge during the ﬁ  fth week of ges-
tation (Wartenberg 1989). Sertoli cells then 
differentiate in the gonadal ridge and sur-
round the germ cells to form the seminiferous 
cords between the sixth and seventh weeks 
(Gondos 1980; Wartenberg 1989). At this 
time, the PGCs are called gonocytes. In par-
allel, Leydig cells diﬀ  erentiate from mesen-
chymal cells in the interstitial compartment 
(Habert et al. 2001). Th   ese steroidogenic cells 
are morphologically discernible at 8 weeks of 
gestation (Huhtaniemi and Pelliniemi 1992), 
whereas in organ culture, testosterone secre-
tion is detected from 6 weeks (Lambrot et al. 
2006). The appropriate onset of gameto-
genesis and steroido  genesis is fundamental 
for the function of reproduction in the adult. 
Indeed, the number of germ cells formed 
during fetal life is essential for adult fertil-
ity. In mutant, germ-cell–deficient (gcd–/–) 
mice charac  terized by a reduced number of 
PGCs, as in mice lacking the POG (prolif-
eration of germ cells) gene, the number of 
fetal germ cells is reduced and adult fertil-
ity is altered (Lu and Bishop 2003). In the 
same way, androgens and insulin-like factor 
3 (Insl3) produced by fetal Leydig cells con-
trol the masculinization of the reproductive 
tract and genitalia (Jost et al. 1973; Kubota 
et al. 2002).
Several studies have described an increas-
ing frequency of male reproductive dis  orders 
in humans, such as a low sperm count and a 
resulting decline in fertility, increased inci-
dence of testicular cancer, cryptorchidism, 
and hypospadias (reviewed by Bay et al. 
2006; Sharpe and Irvine 2004). It has been 
suggested that these alterations are symp-
toms of a single entity called testicular dys-
genesis syndrome (TDS) (reviewed by Sharpe 
2003; Skakkebaek and Jorgensen 2005). It 
is currently thought that TDS is probably 
caused by changes in the development of the 
fetal testis and may result from the eﬀ  ect of 
genetic and/or environmental factors. Th  us, 
TDS could result from exposure to envi-
ronmental chemicals, which have steadily 
increased in diversity and concentration in 
the environment and food (Delbes et al. 
2006; Skakkebaek et al. 2001). Several envi-
ronmental chemicals are classed among the 
so-called endocrine disruptors. Many of them 
act on reproductive functions because of their 
estrogenic and/or antiandrogenic proper-
ties. In the present study we focused on the 
effects of phthalates (phthalic acid esters), 
which are industrial chemicals commonly 
found in many consumer products regularly 
used by humans, such as soap, shampoo, cos-
metics, and hairspray. Th  ey are also used in 
flexible plastics, such as food and beverage 
packaging, children’s toys, and biomedical 
equipment (e.g., blood transfusion bags). 
Di-2-ethylhexyl phthalate (DEHP) is one 
of the most abundant phthalates produced 
(Latini et al. 2006). Latini (2005) demon-
strated that phthalates, when administered 
orally to humans and rodents, are rapidly 
hydrolyzed by esterases in the gut and other 
tissues to produce the corresponding active 
monoesters. For example, DEHP is metabo-
lized to its monoester metabolite, mono-2-
ethylhexyl phthalate (MEHP), which is a 
recognized active testicular toxicant (Fisher 
2004). Phthalates are not covalently bound 
to plastic products and therefore may leak 
out to contaminate blood or food products 
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BACKGROUND: Several studies have described an increasing frequency of male reproductive 
  disorders, which may have a common origin in fetal life and which are hypothesized to be caused 
by endocrine disruptors. Phthalate esters represent a class of environmental endocrine-active 
chemicals known to disrupt development of the male reproductive tract by decreasing testosterone 
production in the fetal rat.
OBJECTIVES: Using the organ culture system we developed previously, we investigated the 
eﬀ  ects on the development of human fetal testis of one phthalate—mono-2-ethylhexyl phthalate 
(MEHP)—an industrial chemical found in many products, which has been incriminated as a dis-
ruptor of male reproductive function. 
METHODS: Human fetal testes were recovered during the ﬁ  rst trimester (7–12 weeks) of gestation, 
a critical period for testicular diﬀ  erentiation, and cultured for 3 days with or without MEHP in 
basal conditions or stimulated with luteinizing hormone (LH). 
RESULTS: Whatever the dose, MEHP treatment had no eﬀ  ect on basal or LH-stimulated testoster-
one produced by the human fetal testis in vitro, although testosterone production can be modu-
lated in our culture system. MEHP (10–4 M) did not aﬀ  ect proliferation or apoptosis of Sertoli 
cells, but it reduced the mRNA expression of anti-Müllerian hormone. MEHP (10–4 M) reduced 
the number of germ cells by increasing their apoptosis, measured by the detection of caspase-
3–positive germ cells, without modiﬁ  cation of their proliferation.
CONCLUSIONS: Th   is is the ﬁ  rst experimental demonstration that phthalates alter the development 
of the germ cell lineage in humans. However, in contrast to results observed in the rat, phthalates 
did not aﬀ  ect steroidogenesis.
KEY WORDS: human fetus, phthalates, testis development. Environ Health Perspect 117:32–37 
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and can be ingested. In an epidemiologic 
study, 75% of the 289 human subjects tested 
were positive for the presence of four diﬀ  er-
ent types of phthalates in their urine samples 
(Blount et al. 2000). In rodents, both in vivo 
and in vitro approaches have been used to 
determine the eﬀ  ects on testicular functions 
of exposure to phthalates (reviewed by Sharpe 
2006). Several studies have shown that fetal 
exposure to di(n-butyl) phthalate (DBP) 
induced by gavage of pregnant rats induces 
TDS-like effects (Barlow and Foster 2003; 
Fisher et al. 2003; Mylchreest et al. 2000).
However, despite the growing body of 
literature on phthalate reproductive toxic-
ity and data demonstrating extensive human 
exposure, very few studies have examined the 
eﬀ  ects of these chemicals on human reproduc-
tive development. Recently, an inverse cor-
relation has been shown between the maternal 
urinary phthalate concentration at the end 
of pregnancy and the anogenital distance at 
birth (Swan et al. 2005). In the same way, a 
dose-dependent association between phtha-
lates in breast milk and levels of reproduc-
tive hormones in boys at 3 months of age has 
also been reported (Main et al. 2006). Th  ese 
findings are particularly important because 
they are the unique epidemiologic studies 
exhibiting negative effects of phthalates at 
environmental concentrations. Until now, no 
experimental study has succeeded in demon-
strating a deleterious eﬀ  ect of phthalates on 
human testis functions or development.
In this study, we focused on phthalate 
eﬀ  ects speciﬁ  cally on the testis. We used the 
organ culture system of human fetal testes 
that we developed previously (Lambrot et al. 
2006), coupled with morphologic, functional, 
and molecular methods (Lambrot et al. 2006, 
2007), to analyze the eﬀ  ects of MEHP on the 
development of testicular somatic and germ 
cells during the ﬁ  rst trimester of pregnancy 
(7–12 weeks of gestation). Th   is early develop-
mental period of the testis has been shown to 
be a critical window for the determination of 
the reproductive tract (Welsh et al. 2008).
Materials and Methods
Collection of human fetal testis. Human fetal 
testes were obtained from pregnant women 
referred to the Department of Obstetrics and 
Gynecology at the Antoine Béclère Hospital 
for legally induced abortion in the ﬁ  rst tri-
mester of pregnancy, that is, from the sev-
enth until the twelfth week of gestation, as 
previously described (Lambrot et al. 2006). 
None of the terminations was for reasons of 
fetal abnormality, and all fetuses appeared 
morphologically normal. The sex of the 
fetus was determined by the morphology of 
the gonads, and the fetal age was evaluated 
by measuring the length of limbs and feet 
(Evtouchenko et al. 1996). Th   e fetuses were 
dissected under a binocular microscope; tes-
tes were removed aseptically and immediately 
explanted in vitro. We found testes within the 
abortive material in only 12% of cases. Th  e 
Antoine Béclère Hospital Ethics Committee 
approved this study.
Organ cultures. We cultured testes on 
Millicell-CM Biopore membranes (pore size, 
0.4 μm; Millipore, Billerica, MA, USA) as 
previously described (Habert et al. 1991; 
Lambrot et al. 2006). We used phenol red–
free Dulbecco’s modified Eagle’s medium/
Ham F12 (1:1) (Gibco, Grand Island, NY, 
USA) supplemented with 80 μg/mL gentami-
cin (Sigma, St. Louis, MO, USA) and devoid 
of hormones, growth factors, and serum. We 
obtained MEHP from TCI Europe (Antwerp, 
Belgium).
Each human testis was cut into small 
pieces, and all pieces from the same testis 
were placed on Millicell membranes ﬂ  oating 
on 320 μL culture medium in tissue culture 
dishes. Tissues were cultured for 4 days at 
37°C in a humidiﬁ  ed atmosphere contain-
ing 95% air/5% carbon dioxide, and the 
medium was changed every 24 hr. We mea-
sured the responses to MEHP (10–6, 10–5, 
and 10–4 M) by comparing one testis cul-
tured in medium containing the tested factor 
with the other testis from the same fetus cul-
tured in control medium. We added luteiniz-
ing hormone (LH; 100 ng/mL) from human 
pituitary (≥ 5,000 IU/mg; Sigma) or keto-
conazole (KTZ; 4 μM; Sigma) every 24 hr 
to the culture medium. Bromodeoxyuridine 
(BrdU 30 μg/mL; Amersham Biosciences, 
Little Chalfont, UK) was added during the 
last 3 hr of culture for the measurement of 
proliferating index. At the end of the culture 
period, explants were frozen in RLT buf-
fer (Qiagen, Valencia, CA, USA) at –20°C 
for RNA analyses, or dry frozen with liquid 
nitrogen for protein analyses. For cellular 
analyses, the explants were ﬁ  xed for 2 hr in 
Bouin’s ﬂ  uid, embedded in paraﬃ   n, and cut 
into 5-μm sections. 
Germ cell counting. We mounted serial 
sections on slides, removed the paraﬃ   n, and 
rehydrated the sections. We then carried 
out immunohistochemical assays for anti-
Müllerian hormone (AMH) as previously 
described (Lambrot et al. 2006) using an anti-
AMH polyclonal antibody (1:2,000; gener-
ously provided by N. Di Clemente, INSERM 
U782, Clamart, France). We visualized per-
oxidase activity using 3,3´-diaminobenzidine 
as substrate. Germ cells were identified as 
AMH-negative cells within the seminiferous 
cords, whereas Sertoli cells were AMH posi-
tive. Counting was performed as previously 
described and validated for rodents (Livera 
et al. 2006; Olaso et al. 1998) and humans 
(Lambrot et al. 2006, 2007). Briefly, we 
counted germ cells in 1 of 10 sections for 
the 7-week-old human fetuses and 1 of 20 
sections for later stages, but never fewer than 
10 sections equidistantly distributed along 
the pieces of testis. We performed all counts 
using Histolab analysis software (Microvision 
Instruments, Evry, France). We counted all 
germ cells on the section and multiplied the 
sum of the values obtained for the observed 
sections of one testis by 10 or 20, respectively, 
to obtain a crude count of germ cells per tes-
tis. We then applied the Abercrombie formula 
(Abercrombie 1946), which uses the average 
measured diameter of the germ cell nuclei and 
the thickness of sections to correct for any 
double counting due to single cells appearing 
in two successive sections. All counts were 
carried out in a blind fashion. 
Immunohistochemical staining for cleaved 
caspase-3. Because caspase-3 is involved in 
most of the apoptotic pathways (Omezzine 
et al. 2003), we used immunodetection of 
caspase-3 to quantify the rate of apoptosis 
as previously described (Delbes et al. 2004; 
Lambrot et al. 2006). We mounted six sec-
tions on a single slide and heated the slide for 
30 min in a permeabilization solution (0.05 
M Tris, pH 10.6). Th  e procedure was then 
the same as for detection of AMH, except 
that the primary antibody was anti-cleaved 
caspase-3, (1:50; Cell Signaling Technology, 
Beverly, MA, USA). Stained and unstained 
germ and Sertoli cells were counted in all six 
sections. For all immunohistochemical stain-
ing, we used tissue sections prepared without 
the primary antibody as negative controls. 
Measurement of BrdU incorporation 
index. We labeled testes with BrdU (label-
ing reagent diluted 1:100 according to the 
instructions of the cell proliferation kit; 
Amersham Biosciences) during the last 3 hr of 
culture. BrdU incorporation into proliferating 
cells was detected by immuno  cytochemistry 
according to the manufacturer’s recommen-
dations, as previously described (Lambrot 
et al. 2006; Livera et al. 2000). The BrdU 
incorporation index was obtained by a blind 
counting of stained and unstained germ or 
Sertoli cell nuclei in all sections.
Testosterone radioimmunoassay. We 
measured the testosterone secreted into the 
medium in duplicate by radioimmuno  assay as 
previously described (Habert et al. 1991). No 
extraction or chromatography was performed 
because 17β-hydroxy-5α-androstan-3-one 
(DHT), the only steroid that significantly 
cross-reacts with testosterone (64%), is 
secreted in minute amounts by the fetal testis 
(George et al. 1987).
Reverse transcription and real-time 
polymerase chain reaction. We performed 
RNA expression in the fetal testis by reverse 
transcriptase (RT) with the High Capacity 
cDNA Reverse Transcription kit (Applied 
Biosystems, Courtabeuf, France), followed Lambrot et al.
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by real-time polymerase chain reaction (PCR) 
as previously described (Lambrot et al. 2007). 
Primers and probes used were designed by 
Applied Biosystems: β-Actin primer, GenBank 
accession no. NM_001101.2 [National Center 
for Biotechnology Information (NCBI) 2008a]; 
AMH, Probe accession no. Hs00174915_
m1 (NCBI 2008b); Insl3, Hs01394273_
m1; P450c17 (cytochrome P450 c17a), 
Hs00164375_m1; P450scc (cytochrome 
P450 11A1), Hs00167984_m1; RPLPO 
(large ribosomal protein PO), NM_053275.3; 
StAR (steroidogenic acute regulatory protein), 
Hs00264912_m1; and Wt1 (Wilms tumor 1), 
Hs01103749_m1. Reactions were carried out 
and ﬂ  uorescence was detected using an ABI 
Prism 7000 apparatus (Applied Biosystems). 
Each sample was run in triplicate, and nega-
tive controls were run for every primer/probe 
combination. Th  e measured amount of each 
cDNA was normalized using β-actin and 
RPLPO or Wt1 for AMH.
Protein extraction and Western blotting. 
One testis was lysed in 20 mM Tris (pH 7.5), 
150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 
1% Triton X-100, 2.5 mM Na4O7P2, 1 mM 
β-glycerol phosphate, 1 mM phenylmethylsul-
fonyl ﬂ  uoride, 1 mM Na3VO4, and 1 μg/mL 
leupeptin. Protein in total cell lysates (5 μg) 
was resolved by sodium dodecyl sulfate poly-
acrylamide gel electrophoresis, electrophoreti-
cally transferred to a polyvinylidene   diﬂ  uoride 
membrane (Amersham Biosciences), and 
probed with antibodies for AMH (same as for 
immunohistochemistry) and β-actin (Sigma). 
We used Cy5-coupled anti-rabbit and Cy3-
coupled anti-mouse secondary anti  bodies 
(Amersham Biosciences), and the blot was 
revealed under ﬂ  uorescence in a Typhoon 9400 
scanner (Amersham Biosciences). We quantiﬁ  ed 
the bands by the volumetric method with the 
software ImageQuant (Molecular Dynamics, 
Sunnyvale, CA, USA).
Statistical analysis. All values are 
expressed as mean ± SEM. For all mRNA 
expression analysis and studies on prolifera-
tion or apoptosis, we evaluated the signifi-
cance of the diﬀ  erences between mean values 
for the treated and untreated testes from the 
same fetus using Wilcoxon’s nonparametric 
paired test (for small samples). For total germ 
cell number counting, we used Student’s 
paired t-test because of the high variability 
in the number of germ cell between ages. 
Concerning testosterone secretion analysis, we 
used one-way analysis of variance (ANOVA) 
to assess the significance of the differences 
for secretion evolution between control and 
treated testes during the 3 days of culture.
Results
Eﬀ  ect of MEHP on Leydig cell function. We 
cultured testes from fetuses at 7–12 weeks of 
development with or without 10–6, 10–5, or 
10–4 M MEHP for 4 days. Daily testoster-
one production was unaﬀ  ected by the addi-
tion of MEHP to the medium (Figure 1A). 
To check the lack of effect of MEHP, we 
analyzed the mRNA expression of various 
enzymes involved in steroidogenesis. MEHP 
treatment did not aﬀ  ect the mRNA expres-
sion of P450c17, P450scc, or StAR (Figure 
1B). MEHP did not modify mRNA expres-
sion of Insl3 produced by fetal Leydig cells, 
which is known to be involved in testicular 
descent (Figure 1C).
To assay the ability of testosterone secre-
tion to be modulated in our organotypic cul-
ture system, we performed cultures with LH 
for testosterone stimulation and with KTZ 
for testosterone inhibition. With 100 ng/mL 
LH, the relative testosterone secretion was 
increased 5-fold at day 3 (Figure 2B). On 
the other hand, treatment with 4 μM KTZ 
(a cytochrome P450 inhibitor), which we 
have determined to be a nontoxic concentra-
tion for the testis (Figure 2A), induced very 
strong inhibition of testosterone production 
from day 2. Using one-way ANOVA, the 
change in testosterone secretion with both 
LH and KTZ treatments differed signifi-
cantly from their respective controls. Th  ese 
results strengthen the validity of testosterone 
measurement in this model.
To investigate the effect of MEHP on 
stimulated testosterone secretion, testes were 
Figure 1. Effect of MEHP on Leydig cell function in the human fetal testis in culture. (A) Testosterone pro-
duced on days 1–3 (D1–D3) of culture measured by radioimmunoassay, compared with production on day 
0. Values (mean ± SEM) are expressed as the percentage of the control value; MEHP 10–6 M, n = 4; MEHP 
10–5 M, n = 3; MEHP 10–4 M, n = 15. (B) Levels of mRNA expression of speciﬁ  c Leydig cell markers using 
quantitative RT-PCR with speciﬁ  c primers to analyze expression of genes encoding P450c17, P450scc, 
StAR, and Insl3. Results (mean ± SEM of three different determinations) were standardized to either 
β-actin or RPLPO as the endogenous control and are presented as a percentage of the control value. 
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cultured in the presence of LH (100 ng/mL) 
with or without 10–4 M MEHP. Relative 
LH-stimulated testosterone production was 
unaﬀ  ected by the addition of MEHP to the 
medium (Figure 3).
Effect of MEHP on Sertoli cell develop-
ment. We studied the ratio of proliferative 
(BrdU positive; Figure 4A) and apoptotic 
(cleaved caspase-3 positive; Figure 4B) Sertoli 
cells after MEHP treatment for 3 days and 
observed that MEHP had no signiﬁ  cant eﬀ  ect 
on these two activities.
We also analyzed the effect of MEHP 
on AMH expression by real-time RT-PCR 
(Figure 5A) and by ﬂ  uorescent Western blot-
ting (Figure 5B). Regardless of the house-
keeping gene (β-actin or RPLPO) or speciﬁ  c 
Sertoli cell marker (Wt1, which is not signiﬁ  -
cantly diﬀ  erent in control and treated samples 
if standardized to β-actin), MEHP signiﬁ  cantly 
decreased the mRNA level of AMH. However, 
the level of AMH protein standardized to 
β-actin was not modiﬁ  ed by MEHP treatment.
Eﬀ  ect of MEHP on fetal germ cell develop-
ment. Addition of 10–6 M, 10–5 M, or 10–4 M 
MEHP for 3 days had no eﬀ  ect on the orga-
nization of the testis at the end of the culture 
(data not shown). Interestingly, regardless of the 
age of the fetus at explantation (from 7 to 12 
gestational weeks), the higher dose of MEHP 
(10–4 M) signiﬁ  cantly reduced the number of 
germ cells. Th   erefore, we expressed the results 
as a percentage of control and pooled the results 
from diﬀ  erent ages (Figure 6A). However, the 
10–6 M concentration had no eﬀ  ect.
Treatment with 10–4 M MEHP sig-
nificantly increased the number of cleaved 
caspase-3–positive germ cells (Figure 
6C,D) without altering their proliferation 
(Figure 6B). Treatment with 10–5 M MEHP 
increased, but not signiﬁ  cantly, the number 
of cleaved   caspase-3–positive germ cells (3.4% 
in the treated vs. 2% in the control testes) 
(Figure 6D).
Discussion
In this study, we investigated the eﬀ  ect of one 
metabolite of phthalate ester, MEHP, on the 
development of human fetal testes, using our 
previously developed and validated organ cul-
ture system (Lambrot et al. 2006, 2007). In 
this organ culture system, the testicular archi-
tecture and intercellular communications are 
preserved enough to allow the development 
of the main fetal testicular cell types in vitro, 
without any added factor (Livera et al. 2006).
This approach allowed us to present 
here the first experimental demonstration 
that phthalates impair the development of 
the male fetal germ cell lineage in the human 
species. After 3 days of treatment, MEHP 
reduced by 40% the number of germ cells in 
cultured human fetal testis. This effect was 
due to a large increase in their apoptosis with-
out modiﬁ  cation of their proliferation. A neg-
ative eﬀ  ect of phthalates on gonocyte number 
has also been reported in rodents both in vivo, 
after gavage (Ferrara et al. 2006), and in vitro, 
in organ culture (Chauvigné F, Menuet A, 
Chagnon M-C, Lesné L, Jegou B, unpub-
lished data; Lehraiki A, Szenker J, Habert R, 
Levacher C, unpublished data; Li and Kim 
2003). It is interesting that, in rodents, 
the androgen pathway does not seem to be 
involved in germ cell number, because phtha-
lates are distinct from ﬂ  utamide in their abil-
ity to induce PGC degeneration (Mylchreest 
et al. 1999).
Phthalates induce the appearance of multi-
nucleated gonocytes in rodents (Ferrara et al. 
2006; Kleymenova et al. 2005). In the present 
study, we observed no multinucleated gono-
cytes in response to MEHP treatment. Th  is 
may be due to a species characteristic; appear-
ance of multinucleated gonocytes in rodents 
depends on the age of the fetus. For example, 
Ferrara et al. (2006) observed  multinucle-
ated gonocytes after DBP gavage only from 
day 19.5 postconception. Th   us, the sensitive 
window in humans may occur later than the 
period studied here.
Phthalates are known as Sertoli cell toxi-
cants in rodents. Some studies have reported a 
decrease in Sertoli cell number or proliferation 
(Hutchison et al. 2008; Li and Kim 2003; Li 
et al. 2000), interference with cytoskeleton 
(Kleymenova et al. 2005), and decrease in 
the expression of Sertoli cell markers (AMH, 
GATA4, inhibin) and of follicle-stimulating 
hormone–stimulated cAMP production 
(Fisher et al. 2003; Heindel and Chapin 1989; 
Hutchison et al. 2008; Li and Kim 2003). 
In this study, we observed that MEHP did 
not aﬀ  ect the proliferation or apoptosis rate 
of Sertoli cells. On the other hand, MEHP 
Figure 5. Effect of 10–4 M MEHP on AMH expression in cultured human fetal testes. (A) Results of 
quantitative RT-PCR with AMH-specific primers (mean ± SEM of three independent samples), nor-
malized to β-actin, RPLPO, Wt1 (Sertoli endogenous control), expressed as a percentage of control. 
(B) Representative ﬂ  uorescent Western blot revealing AMH protein (green) and β-actin (red). DMSO, 
dimethyl sulfoxide.
*p < 0.05 in the paired comparison with the corresponding control values (Wilcoxon paired test). 
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Figure 6. Effect of MEHP on the number and the proliferative and apoptotic activities of germ cells in cultured human fetal tesstes. (A) Total number of germ cells 
per testis expressed as a percentage of the value obtained with MEHP compared with the contralateral testis cultured in the absence of MEHP (mean ± SEM of 
four experiments). (B) Proliferation of the germ cells determined by immunohistochemical detection of BrdU incorporation into the nuclei during the last 3 hr of 
culture (mean ± SEM of three experiments). (C) Micrograph after immunohistochemical detection of cleaved caspase-3, a marker of apoptosis, after culture with 
or without MEHP. Arrowheads, cleaved caspase-3–positive gonocytes; arrows, cleaved caspase-3–negative gonocytes. Scale bars, 10 μm. (D) Percentage of 
labeled gonocytes for cleaved caspase-3 (mean ± SEM of three or four experiments). DMSO, dimethyl sulfoxide.
*p < 0.05 in the paired comparison with the corresponding control values by Student’s t-test in (A) and Wilcoxon paired test in (B). 
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decreased the mRNA expression of AMH 
whether we normalized relative expression to 
ubiquitous expression or to the Sertoli gene. 
Surprisingly, however, the intracellular AMH 
protein level was not modified by MEHP 
treatment when analyzed by Western blot. To 
explain this discrepancy, we can hypothesize 
that MEHP affects RNA expression earlier 
than it does protein expression.
In the rat, it is currently thought that 
phthalates act mainly on fetal Leydig cells. 
Th  us, the main eﬀ  ects of phthalates are the 
suppression of testosterone production, an 
abnormal Leydig cell aggregation, and the 
presence of intratubular Leydig cells (Culty 
et al. 2008; Fisher et al. 2003; Parks et al. 
2000). Jegou and colleagues (Chauvigné F, 
Menuet A, Chagnon M-C, Lesné L, Jegou B, 
unpublished data) have also observed 
a similar decrease in testosterone produc-
tion in organ culture of rat fetal testis, and 
we conﬁ  rmed this result (data not shown). 
Nevertheless, Hallmark et al. (2007) have 
shown that MBP (monobutyl phthalate) 
reduces human chorionic gonadotropin–
stimulated but not basal steroidogenesis in 
rat fetal testis explants. In the present study, 
we observed that MEHP changes neither 
the basal nor the LH-stimulated production 
of testosterone by the human fetal testis in 
culture. Th  is was conﬁ  rmed by the absence 
of modiﬁ  cation of the mRNA levels of ste-
roidogenic enzymes after MEHP treatment. 
Hallmark et al. (2007) also found no in vitro 
eﬀ  ect of phthalates (MBP and DBP) on ste-
roidogenesis of human fetal testis explants 
recovered during the second (15–20 weeks) 
trimester of pregnancy. So, steroidogenesis of 
the human fetus during the ﬁ  rst and second 
trimesters seems not to be sensitive to phtha-
lates. Th  is period in humans corresponds to 
the window studied in the rat model. It is 
interesting that, in mice, MEHP stimulates 
testosterone production both in the fetal tes-
tis (Gaido et al. 2007; Lehraiki A, Szenker 
J, Habert R, Levacher C, unpublished data) 
and in Leydig tumor cells (Gunnarsson et al. 
2008). This lack of effect on testosterone 
production in humans suggests differences 
between species.
Th  e results presented here contrast with 
epidemiologic data in humans (Main et al. 
2006; Swan et al. 2005). We can formu-
late two hypotheses to explain this appar-
ent discrepancy: first, the studies differ in 
phthalate concentration, nature, and dura-
tion of exposure. We chose to investigate 
the eﬀ  ect of phthalate concentrations rang-
ing from 10–6 M to 10–4 M. In a prospec-
tive study on cryptorchidism carried out on 
the phthalate monoester contamination of 
human breast milk, Main et al. (2006) found 
many phthalate monoesters over a large con-
centration range, from 1.5 to 1,410 μg/L, 
which corresponds to about 10–9 M to 10–6 
M for MEHP. In our study, we observed 
no eﬀ  ect at the lower concentration, either 
on steroido  genesis or on gametogenesis. 
However, the mother and thus the fetus are 
exposed to a combination of multiple phtha-
lates (Swan et al. 2005), which could explain 
the need for a greater dose of MEHP to show 
a potent eﬀ  ect in vitro. Second, in our study 
we focused on the eﬀ  ect of MEHP speciﬁ  -
cally on testis, so we cannot rule out that 
the observed eﬀ  ects in epidemiologic studies 
(cryptorchidism and anogenital distance) are 
due to a direct effect of phthalates on the 
reproductive tract.
In the human fetus, intraabdominal tes-
ticular descent to the inner inguinal ring is 
initiated at about 10–14 weeks of gestation 
(Barteczko and Jacob 2000; Klonisch et al. 
2004). A role for Insl3 secreted by diﬀ  eren-
tiated Leydig cells, in development of the 
gubernaculum and this ﬁ  rst phase of testicu  lar 
descent, has emerged after analysis of mice 
genetically modified for Insl3 expression 
(Adham et al. 2002; Ivell and Bathgate 2002; 
Nef and Parada 1999; Zimmermann et al. 
1999). Moreover, underdeveloped gubernac-
ulum (Barlow and Foster 2003) and reduced 
Insl3 expression have been observed after fetal 
exposure to several different phthalates in 
male rats (Lehmann et al. 2004; McKinnell 
et al. 2005; Wilson et al. 2004). We observed 
no eﬀ  ect of 10–4 M MEHP (highest concen-
tration) on the Insl3 mRNA in human testis 
culture, even though our study took place 
during the setup of the testicular descent. 
Laguë and Tremblay (2008) have recently 
demonstrated that MEHP represses Insl3 
transcription by antagonizing testosterone 
action in Leydig cells. Th  us, the absence of 
eﬀ  ect on Insl3 expression observed here can 
be explained by the lack of eﬀ  ect of MEHP 
on testosterone production in our model. 
Nevertheless, androgen receptor antagonists 
seem to have no effect on Insl3 expression 
(McKinnell et al. 2005; Wilson et al. 2004).
In conclusion, this is the ﬁ  rst experimen-
tal demonstration that phthalates, a family 
of compounds known as endocrine disrup-
tors, widely distributed in the environment, 
are able to alter the development of male 
germ cell lineage in humans. This effect is 
not mediated by a decrease in the testoster-
one produced by the Leydig cells, which is 
unchanged. Furthermore, this study shows 
the eﬃ   ciency of our organ culture system in 
investigating the eﬀ  ects and mechanisms of 
action of environmental disruptors on the 
development of the human fetal testis. Lastly, 
our work provides important insight into the 
potential role of exposure to environmental 
pollutants during fetal testicular development 
and their potential deleterious eﬀ  ects on male 
fertility in adulthood.
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